• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Liver resection versus chemoembolization for patients with multifocal hepatocellular carcinoma.多灶性肝细胞癌患者的肝切除术与化疗栓塞术对比
Hepatobiliary Surg Nutr. 2019 Oct;8(5):543-545. doi: 10.21037/hbsn.2019.04.12.
2
Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis.评价多灶性肝细胞癌的最佳治疗方法：倾向评分匹配分析。
World J Gastroenterol. 2022 Aug 7;28(29):3981-3993. doi: 10.3748/wjg.v28.i29.3981.
3
Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus.肝切除术与经动脉化疗栓塞术治疗伴有肝静脉瘤栓的肝细胞癌
Jpn J Clin Oncol. 2015 Sep;45(9):837-43. doi: 10.1093/jjco/hyv089. Epub 2015 Jun 15.
4
Hepatic resection after transarterial chemoembolization increases overall survival in large/multifocal hepatocellular carcinoma: a retrospective cohort study.经动脉化疗栓塞术后肝切除可提高大/多灶性肝细胞癌患者的总生存率：一项回顾性队列研究
Oncotarget. 2017 Jan 3;8(1):408-417. doi: 10.18632/oncotarget.13427.
5
Liver resection for recurrent hepatocellular carcinoma to improve survivability: a proposal of indication criteria.肝切除术治疗复发性肝细胞癌以提高生存率：适应证标准的建议。
Surgery. 2018 Jun;163(6):1250-1256. doi: 10.1016/j.surg.2017.12.022. Epub 2018 Feb 14.
6
Hepatic resection for hepatocellular carcinoma in severely cirrhotic livers.严重肝硬化肝脏的肝细胞癌肝切除术
Hepatogastroenterology. 2003 Mar-Apr;50(50):491-6.
7
Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study.经动脉化疗栓塞术治疗直径超过10厘米的巨大肝细胞癌：一项大型队列研究
Med Oncol. 2015 Mar;32(3):64. doi: 10.1007/s12032-015-0504-3. Epub 2015 Feb 15.
8
Multifocal hepatocellular carcinoma: a narrative review assessing treatment options from the interventional radiologist's perspective.多灶性肝细胞癌：一篇从介入放射科医生角度评估治疗选择的叙述性综述
Ann Palliat Med. 2023 Nov;12(6):1244-1259. doi: 10.21037/apm-23-294. Epub 2023 Aug 9.
9
Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.可切除肝细胞癌的术前经动脉化疗栓塞术对术后患者预后有不利影响。
Aliment Pharmacol Ther. 2008 Feb 15;27(4):338-45. doi: 10.1111/j.1365-2036.2007.03580.x. Epub 2007 Nov 28.
10
Preoperative transarterial chemoembolization (TACE) + liver resection versus upfront liver resection for large hepatocellular carcinoma (≥5 cm): a systematic review and meta-analysis.术前经动脉化疗栓塞术（TACE）联合肝切除术与直接肝切除术治疗大肝细胞癌（≥5厘米）的系统评价和荟萃分析
Acta Chir Belg. 2023 Dec;123(6):601-617. doi: 10.1080/00015458.2023.2256539. Epub 2023 Sep 8.

本文引用的文献

1
Liver Resection for Multiple Hepatocellular Carcinomas: A Japanese Nationwide Survey.肝切除术治疗多发性肝细胞癌：一项日本全国性调查。
Ann Surg. 2020 Jul;272(1):145-154. doi: 10.1097/SLA.0000000000003192.
2
Molecular therapies and precision medicine for hepatocellular carcinoma.肝细胞癌的分子治疗和精准医学。
Nat Rev Clin Oncol. 2018 Oct;15(10):599-616. doi: 10.1038/s41571-018-0073-4.
3
Surgical resection versus transarterial chemoembolization for BCLC intermediate stage hepatocellular carcinoma: a systematic review and meta-analysis.手术切除与经动脉化疗栓塞治疗BCLC中期肝细胞癌的系统评价和Meta分析
HPB (Oxford). 2018 Feb;20(2):110-119. doi: 10.1016/j.hpb.2017.10.004. Epub 2017 Nov 22.
4
Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time?肝癌患者的免疫治疗：是否已经准备好进入黄金时代？
Cancer Immunol Immunother. 2018 Feb;67(2):161-174. doi: 10.1007/s00262-017-2082-z. Epub 2017 Oct 20.
5
Challenges in patient selection for liver resection or transplantation in patients with hepatocellular carcinoma beyond Milan criteria.超出米兰标准的肝细胞癌患者肝切除或肝移植的患者选择挑战。
Hepatobiliary Surg Nutr. 2017 Aug;6(4):287-289. doi: 10.21037/hbsn.2017.07.04.
6
Curative salvage liver transplantation in patients with cirrhosis and hepatocellular carcinoma: An intention-to-treat analysis.肝硬化和肝细胞癌患者的治愈性挽救性肝移植：意向治疗分析。
Hepatology. 2018 Jan;67(1):204-215. doi: 10.1002/hep.29468. Epub 2017 Nov 15.
7
Average treatment effect of hepatic resection versus locoregional therapies for hepatocellular carcinoma.肝切除术与局部区域治疗肝癌的平均治疗效果。
Br J Surg. 2017 Nov;104(12):1704-1712. doi: 10.1002/bjs.10613. Epub 2017 Jul 26.
8
Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria.米兰标准以外的肝细胞癌患者的肝切除与肝移植
Ann Surg. 2016 Oct;264(4):650-8. doi: 10.1097/SLA.0000000000001866.
9
Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma: Do Both Strategies Yield Similar Outcomes?早期肝细胞癌的挽救性肝移植与原位肝移植：两种策略的结果相似吗？
Ann Surg. 2016 Jul;264(1):155-63. doi: 10.1097/SLA.0000000000001442.
10
Surgical treatment of hepatocellular carcinoma in North America: can hepatic resection still be justified?北美肝细胞癌的外科治疗：肝切除术是否仍合理？
J Am Coll Surg. 2015 Apr;220(4):628-37. doi: 10.1016/j.jamcollsurg.2014.12.030. Epub 2015 Jan 6.

Liver resection versus chemoembolization for patients with multifocal hepatocellular carcinoma.

作者信息

Zaydfudim Victor M, Adams Reid B

机构信息

Department of Surgery, Section of Hepatobiliary and Pancreatic Surgery, University of Virginia, Charlottesville, VA, USA.

出版信息

Hepatobiliary Surg Nutr. 2019 Oct;8(5):543-545. doi: 10.21037/hbsn.2019.04.12.

DOI:10.21037/hbsn.2019.04.12
PMID:31673553
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6791989/
Abstract
摘要